Beacon Pointe Advisors, LLC / BMY
Beacon Pointe Advisors, LLC’s Bristol-Myers Squibb Co Position
Does Beacon Pointe Advisors, LLC own Bristol-Myers Squibb Co (BMY)? Yes — 246.1K shares worth $15M (+0.08% of its 13F portfolio) as of Q1 2026, up from 181.1K shares the prior filed quarter.
Position Value
$15M
Q1 2026
Shares
246.1K
% of Portfolio
+0.08%
Quarters Held
30
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 246.1K | $15M | +0.08% |
| Q4 2025 | 181.1K | $10M | +0.07% |
| Q3 2025 | 174.0K | $8M | +0.07% |
| Q2 2025 | 199.2K | $9M | +0.10% |
| Q1 2025 | 208.9K | $13M | +0.14% |
| Q4 2024 | 207.3K | $12M | +0.13% |
| Q3 2024 | 214.6K | $11M | +0.13% |
| Q2 2024 | 228.3K | $9M | +0.11% |
| Q1 2024 | 275.2K | $15M | +0.17% |
| Q4 2023 | 310.9K | $16M | +0.19% |
| Q3 2023 | 370.5K | $22M | +0.27% |
| Q2 2023 | 298.6K | $19M | +0.31% |
| Q1 2023 | 356.6K | $25M | +0.42% |
| Q4 2022 | 327.8K | $24M | +0.46% |
| Q3 2022 | 317.2K | $23M | +0.50% |
| Q2 2022 | 308.2K | $24M | +0.50% |
| Q1 2022 | 309.5K | $23M | +0.31% |
| Q4 2021 | 220.0K | $14M | +0.36% |
| Q3 2021 | 299.2K | $18M | +0.44% |
| Q2 2021 | 149.7K | $10M | +0.35% |
| Q1 2021 | 20.5K | $1M | +0.08% |
| Q4 2020 | 26.6K | $2M | +0.11% |
| Q3 2020 | 22.6K | $1M | +0.13% |
| Q2 2020 | 19.8K | $1M | +0.12% |
| Q1 2020 | 14.0K | $781,000 | +0.12% |
| Q4 2019 | 8.3K | $529,000 | +0.16% |
| Q3 2019 | 5.4K | $276,000 | +0.12% |
| Q2 2019 | 8.1K | $368,000 | +0.13% |
| Q1 2019 | 7.2K | $343,000 | +0.13% |
| Q4 2018 | 7.2K | $374,000 | +0.23% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Beacon Pointe Advisors, LLC’s full portfolio or all institutional holders of BMY.